P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS
Saved in:
Published in | HemaSphere Vol. 6; no. Suppl; pp. 720 - 721 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Lippincott Williams & Wilkins
23.06.2022
Wiley |
Online Access | Get full text |
Cover
Loading…
ISSN: | 2572-9241 2572-9241 |
---|---|
DOI: | 10.1097/01.HS9.0000846188.51290.75 |